{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-8497292","patent":{"patent_number":"US-8497292","title":"Translational dysfunction based therapeutics","assignee":null,"inventors":[],"filing_date":"2008-06-27T00:00:00.000Z","publication_date":"2013-07-30T00:00:00.000Z","cpc_codes":["C12Q","G01N"],"num_claims":13,"abstract":"Provided are methods and compositions for inhibiting eukaryotic translation initiation factor. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Translational dysfunction based therapeutics","description":"Provided are methods and compositions for inhibiting eukaryotic translation initiation factor. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene ther","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-8497292","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-8497292","citation_suggestion":"Patentable. \"Translational dysfunction based therapeutics\" (US-8497292). https://patentable.app/patents/US-8497292","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-8497292","json":"https://patentable.app/api/llm-context/US-8497292","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-30T15:38:28.213Z"}